NR 566 ADVANCED PHARMACOLOGY OF FAMILY
MIDTERM REVIEW EXAM QUESTIONS & ANSWERS
RATED 100% CORRECT
1. Liraglutide baseline data needed HbA1C q 6 months
Renal/Lipid values prn
Can the patient tolerate injections
2. Liraglutide Monitoring and assess- Signs of
ment Cholecystitis
Pancreatitis
depression
Suicidal thoughts
3. Phentermine On-going cardiac assessment
assess- ment with long
term use
4. Toprimate Causes sense of satiety
If weight loss of 5% has not occurred in 6 months
discontinue
If 3% has occurred by 3 months increase dose
5. What would happen if Lorcaserin is Increased serum level of substrate
given with at CYP2D6 substrate?
6. Which weight loss drug 8. On going assessment with
could cause hypothyroidism Naltrex- one/Bupropion
in a pt tak- ing levothyroxine
7. Naltrexone/Bupropion
(Contrave) Baseline data
needed
,NR 566 ADVANCED PHARMACOLOGY OF FAMILY
MIDTERM REVIEW EXAM QUESTIONS & ANSWERS
RATED 100% CORRECT
Prescribe substrate at lower doses
Orlistat
Blood glucose
Liver function
Renal function
Mental status
,NR 566 ADVANCED PHARMACOLOGY OF FAMILY
MIDTERM REVIEW EXAM QUESTIONS & ANSWERS
RATED 100% CORRECT
Blood sugar
Liver/Renal
S/s of depression, anxiety, SI, mania, panic attacks
9. Which weight loss drugs are Contrave (naltrexone/bupropion)
asso- ciated with increased
suicide risk in
children/adolescent/young
adults Decreases ability of opioid analgesics to relieve pai
10. Naltrexone/Bupropion Patient
ed- ucation Gradually, withdrawal sx including seizure may
occur with abrupt discontinuation
11. How to discontinue
phetermine and/or
topiramate
12. Lorcaserin baseline data needed: Rule out
Pulmonary HTN
Valvular disease
13. Lorcaserin On going assessment Cognitive changes
CBC with diff (Blood dyscrasias)
14. Phetermine Baseline data needed Cardiac assessment
15. Ongoing Cardiac assessment
Monitoring/assessment for
Phetermine
16. Lorcaserin patient education: Increased r/o hypoglycemia in DM
Do not take in pregnancy
,NR 566 ADVANCED PHARMACOLOGY OF FAMILY
MIDTERM REVIEW EXAM QUESTIONS & ANSWERS
RATED 100% CORRECT
Do not increase insulin doses
17. Orlistat Patient Education Stools may be oily
Fecal incontinence may occur
Take a Vitamin with A,D,E & K (fat soluble)
Levothyroxine/Orlistat taken 4 hours apart
MIDTERM REVIEW EXAM QUESTIONS & ANSWERS
RATED 100% CORRECT
1. Liraglutide baseline data needed HbA1C q 6 months
Renal/Lipid values prn
Can the patient tolerate injections
2. Liraglutide Monitoring and assess- Signs of
ment Cholecystitis
Pancreatitis
depression
Suicidal thoughts
3. Phentermine On-going cardiac assessment
assess- ment with long
term use
4. Toprimate Causes sense of satiety
If weight loss of 5% has not occurred in 6 months
discontinue
If 3% has occurred by 3 months increase dose
5. What would happen if Lorcaserin is Increased serum level of substrate
given with at CYP2D6 substrate?
6. Which weight loss drug 8. On going assessment with
could cause hypothyroidism Naltrex- one/Bupropion
in a pt tak- ing levothyroxine
7. Naltrexone/Bupropion
(Contrave) Baseline data
needed
,NR 566 ADVANCED PHARMACOLOGY OF FAMILY
MIDTERM REVIEW EXAM QUESTIONS & ANSWERS
RATED 100% CORRECT
Prescribe substrate at lower doses
Orlistat
Blood glucose
Liver function
Renal function
Mental status
,NR 566 ADVANCED PHARMACOLOGY OF FAMILY
MIDTERM REVIEW EXAM QUESTIONS & ANSWERS
RATED 100% CORRECT
Blood sugar
Liver/Renal
S/s of depression, anxiety, SI, mania, panic attacks
9. Which weight loss drugs are Contrave (naltrexone/bupropion)
asso- ciated with increased
suicide risk in
children/adolescent/young
adults Decreases ability of opioid analgesics to relieve pai
10. Naltrexone/Bupropion Patient
ed- ucation Gradually, withdrawal sx including seizure may
occur with abrupt discontinuation
11. How to discontinue
phetermine and/or
topiramate
12. Lorcaserin baseline data needed: Rule out
Pulmonary HTN
Valvular disease
13. Lorcaserin On going assessment Cognitive changes
CBC with diff (Blood dyscrasias)
14. Phetermine Baseline data needed Cardiac assessment
15. Ongoing Cardiac assessment
Monitoring/assessment for
Phetermine
16. Lorcaserin patient education: Increased r/o hypoglycemia in DM
Do not take in pregnancy
,NR 566 ADVANCED PHARMACOLOGY OF FAMILY
MIDTERM REVIEW EXAM QUESTIONS & ANSWERS
RATED 100% CORRECT
Do not increase insulin doses
17. Orlistat Patient Education Stools may be oily
Fecal incontinence may occur
Take a Vitamin with A,D,E & K (fat soluble)
Levothyroxine/Orlistat taken 4 hours apart
